China Isotope & Radiation Corporation (CIRC; HKG: 1763) has announced that it has received a medical device license from the National Medical Products Administration (NMPA) for its innovative gamma beam stereotactic radiotherapy system. This new system represents a significant advancement in the field of radiation therapy.
The product streamlines the diagnostic and treatment process by integrating the information flow of diagnosis, imaging, planning, and treatment. It features an advanced treatment control system (TCS), treatment planning system (TPS), and image guidance system (IGS), which together facilitate digital and intelligent management of the equipment. The system includes a CBCT image guidance system for registration and a six-dimensional bed automatic correction function, ensuring the precision of radiation therapy delivery. With its ultra-high dose rate and robust automation capabilities, the system is designed to enhance patient treatment efficiency and reduce treatment duration. Additionally, the integrated head and body knife design offers a broader range of indications and more powerful functions.- Flcube.com
